Ga-68 FAPI Uptake in a Case of Recurrent Glioblastoma Multiforme
Indian Journal of Nuclear Medicine · 27.04.2026 · 41 · 412-413
DOI: 10.25259/ijnm_146_25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Nuclear Medicine, online erschienen am 27.04.2026. Verfasst von Komal Bishnoi und 6 weiteren Autor:innen. Die Arbeit nennt 6 Literaturangaben.
Abstract (Originalsprache)
Glioblastoma multiforme (GBM) is an aggressive primary brain tumour with a high recurrence despite multimodal therapy. Magnetic resonance imaging done after treatment can be limited by radiation necrosis, while F-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) suffers from high cortical background activity. We present the case of recurrent GBM in which Ga-68 Fibroblast Activation Protein Inhibitor (FAPI) PET/CT demonstrated intense uptake with higher tumour-to-background contrast compared with FDG PET/CT. This case demonstrates the diagnostic potential of FAPI imaging in recurrent GBM and highlights its emerging theranostic relevance as a biomarker for FAPI-targeted radionuclide therapy.
Zitieren
APA
Bishnoi, K., Damle, N. A., Kumar, A., Dharmashaktu, Y., Tripathi, M., Shamim, S. A., & Tandon, V. (2026). Ga-68 FAPI Uptake in a Case of Recurrent Glioblastoma Multiforme. Indian Journal of Nuclear Medicine, 41, 412-413. https://doi.org/10.25259/ijnm_146_25
Vancouver
Bishnoi K, Damle NA, Kumar A, Dharmashaktu Y, Tripathi M, Shamim SA, et al. Ga-68 FAPI Uptake in a Case of Recurrent Glioblastoma Multiforme. Indian Journal of Nuclear Medicine. 2026;41:412-413. doi:10.25259/ijnm_146_25
BibTeX
@article{Bishnoi2026,
author = {Bishnoi, Komal and Damle, Nishikant Avinash and Kumar, Amandeep and Dharmashaktu, Yamini and Tripathi, Madhavi and Shamim, Shamim Ahmed and Tandon, Vivek},
title = {Ga-68 FAPI Uptake in a Case of Recurrent Glioblastoma Multiforme},
journal = {Indian Journal of Nuclear Medicine},
year = {2026},
volume = {41},
pages = {412--413},
doi = {10.25259/ijnm_146_25}
}
EUVIMED